Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HIV home tests

This article was originally published in The Tan Sheet

Executive Summary

FTC charges Internet marketer David Rothbart, doing business as Medimax, Inc., with falsely representing that his HIV tests accurately detect the AIDS virus. An Orlando, Fla. federal judge issued a temporary restraining order against Rothbart, barring him from marketing or selling the tests and freezing his assets. FTC alleges that, contrary to Rothbart's promotional materials promising his tests are 99% accurate, "nine of ten of Rothbart's HIV tests provided false negative results when tested with HIV-positive blood; the tenth test did not work at all." The commission also takes issue with Rothbart's sale of a "rapid test" that supposedly gives accurate results in 15 minutes; such HIV tests are not approved for U.S. sale, FTC says. In November, Cyberlinx Marketing settled FTC charges the Internet company falsely represented HIV home test kits as accurately detecting the virus (1"The Tan Sheet" Nov. 29, In Brief)

You may also be interested in...



HIV home tests

Alfa Scientific Designs enjoined from advertising, marketing or selling any HIV tests under a stipulated preliminary injunction filed in San Diego federal court Jan. 13. In a complaint for permanent injunction, FTC alleges that since at least October 1998 Alfa Scientific has marketed HIV tests through its Web site, falsely representing their accuracy. The commission also contends Alfa Scientific supplied faulty HIV tests to Medimax, Inc. and its owner, David Rothbart. In December, FTC charged Medimax with falsely representing through the Internet the accuracy of its HIV test kits. Medimax is preliminarily enjoined from marketing the tests (1"The Tan Sheet" Dec. 13, 1999, p. 2)

HIV home tests

Alfa Scientific Designs enjoined from advertising, marketing or selling any HIV tests under a stipulated preliminary injunction filed in San Diego federal court Jan. 13. In a complaint for permanent injunction, FTC alleges that since at least October 1998 Alfa Scientific has marketed HIV tests through its Web site, falsely representing their accuracy. The commission also contends Alfa Scientific supplied faulty HIV tests to Medimax, Inc. and its owner, David Rothbart. In December, FTC charged Medimax with falsely representing through the Internet the accuracy of its HIV test kits. Medimax is preliminarily enjoined from marketing the tests (1"The Tan Sheet" Dec. 13, 1999, p. 2)

HIV home tests

Alfa Scientific Designs enjoined from advertising, marketing or selling any HIV tests under a stipulated preliminary injunction filed in San Diego federal court Jan. 13. In a complaint for permanent injunction, FTC alleges that since at least October 1998 Alfa Scientific has marketed HIV tests through its Web site, falsely representing their accuracy. The commission also contends Alfa Scientific supplied faulty HIV tests to Medimax, Inc. and its owner, David Rothbart. In December, FTC charged Medimax with falsely representing through the Internet the accuracy of its HIV test kits. Medimax is preliminarily enjoined from marketing the tests (1"The Tan Sheet" Dec. 13, 1999, p. 2)

Related Content

Topics

UsernamePublicRestriction

Register

PS090671

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel